Non-Infectious Disease

Reading data like a scientist means looking past the headline number to understand what it really represents. Incidence rate is the number of new cases divided by the population size, multiplied by a standard multiplier (usually 100,000). This adjustment lets you compare a town of 5,000 with a city of 500,000 fairly. Without this adjustment, raw counts are meaningless for comparison.

Case fatality rate shows how deadly a disease is, but only among people who are diagnosed. It does not tell you how likely you are to die if you are infected but asymptomatic, or how many people were never tested. Vaccine efficacy shows protection under ideal conditions, but real-world effectiveness may differ. Context, who was studied, where, and when, transforms a number from a soundbite into useful information.

A hypothesis is a testable prediction based on scientific reasoning. It is not a guess, and it is not a question. It should make the expected relationship between the independent and dependent variables clear and explain the scientific reason for the prediction. One useful scaffold is: If [independent variable], then [dependent variable] will [change], because [scientific reason]. You can use another clear structure that states a testable prediction and its scientific reasoning.

A weak hypothesis is vague, untestable, or disconnected from science. A strong hypothesis gives you something concrete to measure and a reason to expect a particular outcome. When you write your depth study hypothesis, imagine you are explaining your prediction to a scientist who knows the field but does not know your specific experiment. Would they understand why you expect this result?

Non-infectious diseases are not normally passed from person to person as infections. They include cardiovascular disease, type 2 diabetes, cancers, autoimmune diseases, and neurodegenerative conditions. Their causes and risk factors vary. Some infections, such as certain HPV infections, can contribute to the development of cancer: the virus can be transmitted, but the cancer itself is not spread through ordinary contact. Prevention therefore involves reducing relevant risk factors, which can include preventing infections linked to some cancers.

Lifestyle modification: The most powerful prevention tool for many non-infectious diseases. Not smoking, maintaining a healthy weight, eating a balanced diet, exercising regularly, limiting alcohol, and protecting skin from UV radiation significantly reduce risk. The Cancer Council estimates that about one-third of all cancers are preventable through lifestyle changes.

Screening programs: Detect disease early when treatment is more effective. Australia has national screening programs for breast cancer (BreastScreen Australia), cervical cancer (National Cervical Screening Program), bowel cancer (National Bowel Cancer Screening Program), and newborn metabolic disorders.

Genetic counselling: For people with family histories of hereditary diseases (like BRCA-related breast cancer), genetic testing and counselling help assess risk and guide preventive decisions.

Not every health problem is a disease caused by a pathogen or a lifestyle risk. A disorder is a condition in which part of the body does not work as it should, and some of the most important Australian medical technologies were built to work around a part that has failed. The best of them start from a precise understanding of which part has failed and why.

The cochlear implant (Graeme Clark, University of Melbourne, 1978). In the most common form of profound deafness, the ear still collects sound, but the hair cells inside the cochlea are damaged, so the vibrations are never converted into electrical signals in the auditory nerve. A hearing aid only makes sound louder, which cannot help if nothing is there to detect it. Clark's multichannel implant skips the damaged step. A microphone and processor worn behind the ear turn sound into a coded electrical signal, which is sent through the skin to a receiver implanted under it. A thin array of electrodes threaded into the spiral cochlea then stimulates the auditory nerve directly. Because the cochlea responds to high pitches near its base and low pitches near its tip, stimulating different electrodes lets the brain hear different pitches. Clark famously worked out how to thread the electrode by pushing a blade of grass into a spiral seashell on a beach. The first multichannel implant was placed in 1978, and the Australian company Cochlear has since supplied implants to hundreds of thousands of people worldwide.

CPAP for sleep apnoea (Colin Sullivan, University of Sydney, 1980). In obstructive sleep apnoea, the muscles of the throat relax during sleep until the airway collapses and breathing stops, sometimes hundreds of times a night. Oxygen levels fall, sleep is broken, and over years the risk of high blood pressure, heart disease and accidents rises. Sullivan's continuous positive airway pressure (CPAP) machine blows air through a mask at a slightly raised pressure, which holds the soft airway open like a splint made of air. It does not cure the disorder, it manages it every night, and it became the standard treatment worldwide and the basis of the Australian company ResMed.

Both technologies share a pattern worth noticing: they came from identifying a single mechanism that had failed, then designing a device to bypass or support exactly that step.

Spray-on skin for burns (Fiona Wood and Marie Stoner, Royal Perth Hospital, 1990s). Severe burns are physical trauma: the skin, the body's first line of defence, is destroyed, so the patient loses fluid and is open to infection. A conventional skin graft moves a sheet of healthy skin from elsewhere on the body, but a patient with large burns may not have enough unburnt skin to cover them, and the wound heals slowly. Wood and Stoner's method takes a small sample of healthy skin, about the size of a postage stamp, separates its living cells into a liquid, and sprays them over the wound, where they spread and regrow a new surface far faster than the wound could heal on its own, with less scarring. After the 2002 Bali bombings, Wood's team in Perth treated many of the most severely burned survivors. The method is now sold worldwide as ReCell, and Wood was named Australian of the Year in 2005.

The HPV vaccine (Ian Frazer and Jian Zhou, University of Queensland, 1991). Human papillomavirus (HPV) causes almost all cervical cancers. Frazer and Zhou found a way to make the virus's outer shell protein assemble into empty virus-like particles. These look like the virus to the immune system, so it makes antibodies and memory cells, but they contain no viral DNA, so they cannot cause infection. The particles became the basis of the Gardasil vaccine. In 2007 Australia became one of the first countries to vaccinate schoolchildren against HPV, and Australia is on track to eliminate cervical cancer as a public health problem by 2035. This is the same "train the immune system with a harmless copy" idea from the vaccination lessons, and the reason Professor Frazer appears in this unit's Australian scientists panels.

Evaluating these advances means asking more than "does it work?". None of them was quick: Clark began his research in 1967, eleven years before the first implant; Frazer and Zhou's 1991 particles reached an approved vaccine in 2006; spray-on skin was used on patients years before it became a product sold worldwide. Each is expensive; and access is uneven, since specialist surgery and follow-up care are harder to reach in rural and remote Australia. A technology addresses a disorder, a trauma or a disease only for the people who can actually get it.